Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Aurealis Therapeutics and Xbiome Enter into a License and Collaboration Agreement for Aurealis Four-in-One Diabetic Foot Ulcer and Inflammatory Disease Cell and Gene Therapy AUP-16 in Greater China 2022-01-29 05:28
Much Awaited, Much Needed: TRANSFORM II Randomized Controlled Trial, by Fondazione RIC, gets rolling 2022-01-28 20:34
Getinge Year End Report 2021: "Healthy order growth, improved EBITA margin and strong cash flow" 2022-01-28 15:14
ESTA launches "ULTRABloom" Foam Hand Sanitiser, that is alcohol free with natural moisturising floral botanicals 2022-01-28 13:34
Ready to Enter the Middle East Market, Vazyme Showcases Its COVID-19 Testing Solutions at Medlab Middle East 2022 2022-01-28 13:00
HaemaLogiX and Lonza Collaborate to Manufacture KappaMab, a Multiple Myeloma Drug Candidate 2022-01-28 05:30
Enable Injections Announces $215 Million Financing 2022-01-27 23:35
FDA Grants Breakthrough Therapy Designation for Dizal Pharmaceutical's DZD9008 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR Exon20 Insertion 2022-01-27 21:15
Brii Bio Appoints Karen D. Neuendorff as Chief People Officer and Head of Human Resources 2022-01-27 21:00
Exyte Closes 2021 with Record Order Intake 2022-01-27 20:53
Mentice's CEO Goran Malmberg to present the company's Year-end Report Q4 2021 at a webcast conference call on February 3rd at 9:30 CET 2022-01-27 17:42
Yamagata Food Fair to Be Held in Taichung City, Taiwan from February 11 to 13, Featuring "Healthy" and "Safe" Food at Yumouya Gongyi Store 2022-01-27 14:00
ClinChoice Looks to Advance Global Safety Operations with LifeSphere MultiVigilance 2022-01-27 09:00
iMediSync Successfully Launches the Future of Tele-Medicare at CES 2022 2022-01-27 08:00
TriNetX Announces the Appointment of Shogo Wakabayashi as Japan Country Manager 2022-01-27 08:00
Lipidor Announces Enrolment of First Patients in a Phase III Study on AKP02 for Treatment of Psoriasis 2022-01-26 21:57
SOPHiA GENETICS Appoints Ken Freedman as Chief Revenue Officer 2022-01-26 21:57
Ascletis Announces IND Filing of Its Second FASN Inhibitor ASC60 for Advanced Solid Tumors Accepted by China NMPA 2022-01-26 19:00
Singapore Grants Approval for INDICAID COVID-19 Rapid Antigen Test as Consumer Self-test for SARS-CoV-2 Control 2022-01-26 17:18
Singapore Grants Approval for INDICAID COVID-19 Rapid Antigen Test as Consumer Self-test for SARS-CoV-2 Control 2022-01-26 17:15
1 250 251 252 253 254 753